ArticleBlood advances2019

Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia.

Brian M Barth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.